| Mumbai, February 12, 2008: Roche Diagnostics, one of the leading global diagnostics companies, and Mankind Pharma, one of India's fastest growing pharmaceutical companies, today announced an exclusive marketing agreement wherein Mankind Pharma will undertake marketing activities for Accu-Chek Go, a newly launched blood glucose monitoring device by Roche Diagnostics, in India. |
| Accu-Chek Go is a new, fast, low blood volume system that offers advanced and accurate testing with its hygienic test strip ejection and customizable safety settings. |
| With Mankind's strong distribution and marketing force, Accu-Chek Go will be available across 500 cities in India. The purpose of this co-operation is to raise awareness for diabetes and to spread the message of self-monitoring in Indian homes. Both parties have the declared goal to enable people with diabetes leading a life as normal as possible despite their condition and to provide efficient and effective diabetes management solutions to them in metros, mini metros and rural towns in India. |
| Speaking at this momentous occasion, Mr. Sanjeev Johar, Asia Pacific Regional Head, Diabetes Care, Roche Diagnostics, said, "Globally we have been at the forefront of creating pioneering products and solutions in blood glucose monitoring. Diabetes has reached epidemic proportions in India and accessibility of services for improved diabetes management has always been a challenge. This arrangement provides India's vast urban and suburban areas access to our best-in-class products and services, and aligns perfectly with our philosophy of meeting 'unmet needs' in our chosen markets." |
| Mr. R. C. Juneja, Managing Director, Mankind Pharma said, "We are delighted to announce our partnership with Roche Diagnostics, a market leader in diabetes care. The synergy between Mankind and Roche to provide best solutions in diabetes management is ideal for both parties. This partnership will also strengthen our existing distribution channels thereby expanding Mankind Pharma's presence in the marketplace in the field of diabetes management and diagnosis." |
| The focus of the co-operation is to leverage the importance of proper diabetes management and at the same time to increase the availability of efficient tools for people with diabetes and their caregivers. With the agreement on Accu-Chek Go both partners seek to fulfill the increasing demand of information, adequate education and supply to all parties involved in diabetes management. |
| About Accu-Chek Go |
| The small, sleek Accu-Chek Go gives competent support to people with diabetes: the meter features an adjustable personalized blood glucose target range and its "alarm clock" function has four individually programmable alarm times. In addition the Accu-Chek Go meter offers even more outstanding features that make monitoring blood glucose levels convenient and reliable: the test strip's capillary fill function means the application of blood is fast, easy and hygienic; reliable results are ready in about five seconds; and the strip ejector allows disposing of used test strips without handling them. And testing with Accu-Chek Go is safe: it includes under dosing detection and test strip expiry warning. Additionally it looks modern and appealing: the meter's fresh design and sparkling iridescent surface make it another attractive member of the Accu-Chek family |
| Pricing of Accu-Chek Go Kit |
| Accu-Chek Go Kit is priced at INR 1990. The kit contains: - |
| Accu-Chek Go Meter |
| Accu-Chek Softclix lancing device and lancets |
| Accu-Chek Go Strips 10s |
| About Roche |
| Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totalled 36.8 billion Swiss francs, and sales by the Diagnostics Division totalled 9.3 billion Swiss francs. Roche Diabetes Care posted 2007 sales of 3.2 billion Swiss francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 79,000 people. Additional information is available on the Internet at www.roche.com. |
| About Roche Diabetes Care |
| Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, the Accu-Chek brand has been committed to enable people with diabetes to live life as normal and active as possible as well as to help healthcare professionals manage their patients' condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and services and comprehensive solutions for convenient, efficient and effective diabetes management spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. |
| For more information, please visit www.accu-chek.com. |
| About Mankind Pharma |
| Mankind is a leading and among the top 5 fastest growing pharmaceutical companies of India. It is ranked 2nd in India as per ORG-IMS, Prescription per month per doctor Audit, 2007. Mankind has a strong market presence in Antibiotics, Antifungal, Nutritionals, Gastrointestinal, NSAIDs, Anthelmintics, Cardiovascular, Dermatology, Anti-diabetic and Erectile Dysfunction categories. As per ORG-IMS Secondary Stockist Audit 2007, there are 10 brands ranked no. 1 in the respective categories and 59 brands appear in top 5 positions. In 2007, Mankind totaled 5.15 billion Indian Rupees. Mankind employs 3500, and has joint venture with Magnet Labs Private Limited for antipsychotic segment. |
Top Section
Explore Business Standard